The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Figure 19.5

CSR Figure 19.5: SEER Delay Adjusted Incidence Rates for SEER 9 and SEER 13 Areas, Males


Figure 19.5

Rates per 100,000 for Non-Hodgkin Lymphoma, All Races, Male, All Ages
Year Delay-Adjusted SEER 9 Incidence
1975-2010
Delay-Adjusted SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Observed SEER 9 Incidence
1975-2010
Observed SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Delay-Adjusted SEER 13 Incidence
1992-2010
Delay-Adjusted SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
Observed SEER 13 Incidence
1992-2010
Observed SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
1975 12.9 12.3 12.9 12.3    
1976 12.8 12.8 12.8 12.8    
1977 12.9 13.4 12.9 13.3    
1978 14.3 13.9 14.3 13.9    
1979 14.2 14.5 14.2 14.5    
1980 15.0 15.1 15.0 15.1    
1981 15.9 15.7 15.9 15.7    
1982 15.6 16.4 15.6 16.4    
1983 16.6 17.1 16.6 17.1    
1984 18.3 17.8 18.3 17.8    
1985 18.4 18.6 18.4 18.6    
1986 19.4 19.3 19.4 19.4    
1987 20.8 20.2 20.8 20.2    
1988 21.3 21.0 21.3 21.0    
1989 21.7 21.9 21.6 21.9    
1990 23.0 22.8 23.0 22.9    
1991 23.7 23.8 23.7 23.8    
1992 23.1 23.9 23.0 23.9 23.3 23.8 23.3 23.9
1993 23.5 24.0 23.5 24.0 23.4 23.9 23.4 23.9
1994 25.0 24.1 25.0 24.1 24.8 23.9 24.8 24.0
1995 25.4 24.2 25.4 24.1 25.1 24.0 25.1 24.0
1996 24.3 24.3 24.2 24.2 24.6 24.0 24.6 24.0
1997 24.5 24.4 24.5 24.3 24.0 24.1 23.9 24.1
1998 23.0 24.5 23.0 24.4 23.1 24.2 23.0 24.1
1999 24.6 24.6 24.6 24.5 24.4 24.2 24.4 24.2
2000 24.3 24.7 24.2 24.6 23.6 24.3 23.5 24.2
2001 24.4 24.8 24.4 24.6 24.1 24.4 24.0 24.2
2002 24.3 24.9 24.2 24.7 23.9 24.4 23.8 24.3
2003 25.1 25.0 25.0 24.8 24.3 24.5 24.2 24.3
2004 26.0 25.1 25.9 24.9 25.2 24.5 25.1 24.3
2005 25.7 25.2 25.6 25.0 24.8 24.6 24.7 24.4
2006 24.8 25.3 24.6 25.1 24.1 24.7 23.9 24.4
2007 26.2 25.4 26.0 25.2 25.2 24.7 25.0 24.5
2008 25.8 25.6 25.5 25.2 24.9 24.8 24.7 24.5
2009 25.3 25.7 24.9 25.3 25.0 24.9 24.7 24.5
2010 26.7 25.8 26.3 25.4 25.6 24.9 25.2 24.6
2011 24.8 25.9 24.1 25.5 24.2 25.0 23.5 24.6
Rates per 100,000 for Non-Hodgkin Lymphoma, White, Male, All Ages
Year Delay-Adjusted SEER 9 Incidence
1975-2010
Delay-Adjusted SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Observed SEER 9 Incidence
1975-2010
Observed SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Delay-Adjusted SEER 13 Incidence
1992-2010
Delay-Adjusted SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
Observed SEER 13 Incidence
1992-2010
Observed SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
1975 13.5 12.6 13.5 12.6    
1976 13.3 13.2 13.3 13.2    
1977 13.5 13.8 13.5 13.8    
1978 14.8 14.4 14.8 14.4    
1979 14.6 15.0 14.6 15.0    
1980 15.3 15.7 15.3 15.7    
1981 16.3 16.4 16.3 16.4    
1982 16.4 17.1 16.4 17.2    
1983 17.5 17.9 17.5 17.9    
1984 19.1 18.7 19.1 18.8    
1985 19.2 19.5 19.2 19.6    
1986 20.6 20.4 20.6 20.5    
1987 22.1 21.3 22.1 21.4    
1988 22.4 22.3 22.4 22.4    
1989 23.0 23.3 23.0 23.4    
1990 24.0 24.3 23.9 24.4    
1991 24.8 24.4 24.8 24.5    
1992 24.0 24.6 24.0 24.7 24.5 24.8 24.4 24.3
1993 24.3 24.7 24.3 24.8 24.6 24.9 24.5 24.9
1994 25.6 24.9 25.6 24.9 25.8 25.0 25.8 25.6
1995 26.2 25.0 26.1 25.0 26.3 25.1 26.2 26.3
1996 25.3 25.2 25.2 25.1 25.9 25.2 25.9 25.7
1997 25.3 25.3 25.2 25.2 24.9 25.3 24.9 25.2
1998 24.1 25.5 24.0 25.3 24.3 25.4 24.2 24.7
1999 25.5 25.6 25.5 25.4 25.5 25.5 25.4 24.9
2000 25.7 25.8 25.6 25.5 25.1 25.6 25.0 25.0
2001 25.5 25.9 25.4 25.6 25.3 25.7 25.2 25.2
2002 25.6 26.1 25.5 25.7 25.3 25.8 25.1 25.4
2003 26.5 26.2 26.3 25.9 25.9 25.9 25.7 25.5
2004 27.1 26.4 26.8 26.0 26.6 26.0 26.4 25.7
2005 27.0 26.5 26.7 26.1 26.2 26.1 25.9 25.9
2006 26.3 26.7 25.9 26.2 25.8 26.2 25.5 26.1
2007 27.9 26.9 27.4 26.3 27.2 26.3 26.8 26.2
2008 27.1 27.0 26.5 26.4 26.5 26.4 26.0 26.4
2009 27.0 27.2 26.3 26.5 26.8 26.5 26.2 26.6
2010 27.8 27.3 27.0 26.6 27.2 26.7 26.4 25.8
2011 26.3 27.5 25.0 26.8 26.0 26.8 24.8 25.1
Rates per 100,000 for Non-Hodgkin Lymphoma, Black, Male, All Ages
Year Delay-Adjusted SEER 9 Incidence
1975-2010
Delay-Adjusted SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Observed SEER 9 Incidence
1975-2010
Observed SEER 9 Incidence
1975-2010
Modeled (from Joinpoint)
Delay-Adjusted SEER 13 Incidence
1992-2010
Delay-Adjusted SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
Observed SEER 13 Incidence
1992-2010
Observed SEER 13 Incidence
1992-2010
Modeled (from Joinpoint)
1975 7.3 7.5 7.3 7.5    
1976 7.4 7.9 7.4 7.9    
1977 7.2 8.4 7.2 8.3    
1978 9.5 8.8 9.5 8.8    
1979 11.8 9.3 11.8 9.3    
1980 10.9 9.8 10.9 9.8    
1981 10.6 10.3 10.6 10.3    
1982 10.2 10.9 10.2 10.9    
1983 10.9 11.5 10.9 11.5    
1984 12.5 12.1 12.5 12.1    
1985 12.0 12.7 12.0 12.8    
1986 13.1 13.4 13.1 13.4    
1987 10.6 14.2 10.6 14.2    
1988 15.8 14.9 15.8 15.0    
1989 14.2 15.7 14.2 15.8    
1990 17.5 16.6 17.5 16.6    
1991 18.7 17.5 18.7 17.5    
1992 18.8 18.4 18.7 18.5 19.0 19.4 19.0 19.5
1993 19.4 19.4 19.4 19.5 17.7 19.4 17.7 19.5
1994 21.6 20.5 21.6 20.6 20.4 19.4 20.3 19.5
1995 23.6 20.4 23.5 20.5 21.5 19.4 21.5 19.4
1996 18.9 20.4 18.9 20.4 18.7 19.4 18.6 19.4
1997 24.1 20.4 24.0 20.3 23.0 19.4 22.9 19.4
1998 16.8 20.4 16.7 20.2 17.6 19.5 17.5 19.3
1999 18.5 20.3 18.4 20.1 18.7 19.5 18.6 19.3
2000 18.4 20.3 18.2 20.1 17.6 19.5 17.5 19.3
2001 18.4 20.3 18.3 20.0 18.3 19.5 18.2 19.2
2002 17.4 20.3 17.2 19.9 18.2 19.5 18.0 19.2
2003 19.7 20.2 19.4 19.8 19.3 19.5 19.1 19.2
2004 24.4 20.2 24.1 19.7 22.4 19.5 22.1 19.1
2005 20.4 20.2 20.0 19.7 19.9 19.6 19.5 19.1
2006 20.9 20.1 20.5 19.6 19.6 19.6 19.2 19.1
2007 19.1 20.1 18.6 19.5 18.1 19.6 17.7 19.1
2008 19.3 20.1 18.8 19.4 19.3 19.6 18.8 19.0
2009 19.1 20.1 18.4 19.3 19.5 19.6 18.9 19.0
2010 23.7 20.0 22.7 19.3 22.0 19.6 21.1 19.0
2011 18.3 20.0 17.1 19.2 18.2 19.6 17.1 18.9
Annual Percent Changes for the most recent trend in the data series as calculated by Joinpoint
Non-Hodgkin Lymphoma, Male, All Ages
Data Series Year Range for APC APC
Delay-Adjusted SEER 9 Incidence, All Races, 1975-20101991-110.4*
Observed SEER 9 Incidence, All Races, 1975-20101991-110.3*
Delay-Adjusted SEER 13 Incidence, All Races, 1992-20101992-110.3*
Observed SEER 13 Incidence, All Races, 1992-20101992-110.2
Delay-Adjusted SEER 9 Incidence, White, 1975-20101990-110.6*
Observed SEER 9 Incidence, White, 1975-20101990-110.4*
Delay-Adjusted SEER 13 Incidence, White, 1992-20101992-110.4*
Observed SEER 13 Incidence, White, 1992-20102009-11-2.9
Delay-Adjusted SEER 9 Incidence, Black, 1975-20101994-11-0.1
Observed SEER 9 Incidence, Black, 1975-20101994-11-0.4
Delay-Adjusted SEER 13 Incidence, Black, 1992-20101992-110.1
Observed SEER 13 Incidence, Black, 1992-20101992-11-0.2

Footnotes:

a Source: SEER 9 areas and SEER 13 areas. Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103).

Regression lines and APCs are calculated using the Joinpoint Regression Program Version 4.1.0, April 2014, National Cancer Institute.

The APC is the Annual Percent Change for the regression line segments.

* The APC is significantly different from zero (p < 0.05).

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.